Keywords: neuroimmunophilin, enters, clinical, trials, guilford, pharmaceuticals, amgen

Neuroimmunophilin enters clinical trials

Article | 05 August 1999

Print This

Guilford Pharmaceuticals and Amgen of the USA have started the firstclinical trial of one of their neuroimmunophilin compounds, NIL-A, which ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in